What Is an Acute Dermal Toxicity Test?

Acute dermal toxicity tests, which play a significant role in product safety assessments, are conducted to determine the toxic effects a substance may cause following a single instance of skin contact. These studies are particularly important in the development processes of pharmaceuticals, biocidal products, chemicals, pesticides, medical devices, and industrial products.

At NanoTox, we conduct internationally recognized in vivo toxicity studies using our laboratory infrastructure compliant with GLP (Good Laboratory Practice) standards.

Purpose of the Acute Dermal Toxicity Test

Acute dermal toxicity studies evaluate the potential toxic effects that may result from exposure to the test substance via the skin. These tests help determine the safety profile of products and enable risk assessments regarding human health.

The data obtained plays a significant role in:

• Product safety assessments,
• Chemical classification processes,
• Labeling requirements,
• Regulatory applications,
• And regulatory compliance.

Studies Conducted in Compliance with OECD Guidelines

Acute Dermal Toxicity tests conducted at NanoTox are carried out in accordance with internationally recognized OECD test guidelines. One of the most commonly used methods is:

• OECD 402 – Acute Dermal Toxicity.

Studies conducted in accordance with this guideline ensure the generation of reliable toxicological data accepted by international authorities.

GLP-Compliant In Vivo Testing Services

GLP principles ensure quality assurance throughout the processes of planning, conducting, monitoring, recording, and reporting studies.

At NanoTox:

• With our modern laboratory infrastructure,
• our experienced team of experts,
• our study processes compliant with international standards,
• and our science- and quality-focused approach, we deliver reliable and reproducible results.

Parameters Evaluated in Acute Dermal Toxicity Studies

Throughout the test, various clinical and toxicological findings are closely monitored. These include:

• Clinical observations,
• Skin reactions,
• Behavioral changes,
• Body weight monitoring,
• Mortality and morbidity assessments,
• Pathological examinations.

Through these comprehensive evaluations, the potential toxic effects that the tested product may cause following dermal exposure are analyzed.

Reliable Toxicity Studies with NanoTox

NanoTox conducts Acute Dermal Toxicity studies in accordance with international quality standards as part of its GLP-compliant in vivo testing services. We offer professional solutions to reliably obtain the scientific data required for product safety and regulatory processes.

For detailed information about Acute Dermal Toxicity tests and our other toxicology services, please contact NanoTox.